December 2014
 << <Sep 2017> >>


Who's Online?

Member: 0
Visitor: 1

rss Syndication

Posts sent on: 2014-12-10


Usa Cycling Chief Executive Johnson To Retire

EST December 9, 2014 1 CONNECT 8 TWEET LINKEDIN COMMENTEMAILMORE COLORADO SPRINGS, Colo. (AP) Steve Johnson, the president and CEO of USA Cycling, plans to retire after the United States hosts the road world championships next year in Richmond, Virginia. Johnson said Tuesday in a statement that he was ready to step away after 15 years working for Kim Kardashian the sport's national governing body. Along with serving as chief executive, Johnson also has been its director of athletics and chief financial officer. He took to learn more over amid a storm of controversy. Not only were several American athletes, including Lance Armstrong, embroiled in doping scandals, the organization itself was in financial peril.

Admin · 405 views · Leave a comment

Belgian Pledge Pushes Green Climate Fund To $10 Billion Goal - Yahoo News

main page width='200px' />

The deal is expected to be finalized in Paris in a year's time. The U.N. said earlier this year it hoped the initial links round of pledges would reach $10 billion to encourage progress in the Lima negotiations. The GCF said last week that pledges totaled $9.95 billion, led by up to $3 billion by the United States. "It will be formally announced a bit later today," a Belgian official said, confirming Belgian media reports but asking not to be named. The fund is meant to help poor nations cut their greenhouse gas emissions and adapt to climate change, such as more desertification, more powerful storms and rising sea levels.

Admin · 304 views · Leave a comment

Germany Names 16 Companies With Drugs Suspended Over Indian Data - Yahoo News

Reddy's, that produce drugs affected by its suspension of marketing approval over concerns about clinical trials conducted by an Indian company. Regulators in France, Germany, Belgium and Luxembourg last week suspended marketing approval for 25 drugs over the quality of trial data from India's GVK Biosciences. Germany's Federal Institute for Drugs and Medical Devices (BfArM) on Tuesday published a list of 80 affected products, including multiple entries for different dosages of the same active ingredients, and the drugmakers that marketed them. The companies affected also include U.S. drugmaker Mylan as well as German subsidiaries of India's Torrent Pharmaceuticals and Lupin. The drugs include generic versions of blood thinner Plavix, also called clopidogrel, or generic version of heartburn treatment Nexium, or esomeprazol. BfArM said there is no shortage of freely available treatments that have the same active ingredients as the suspended drugs. French and German regulators have said they were investigating the drug approvals based on clinical trials, which were meant to show that these generic drugs were equivalent to the original branded versions, conducted by GVK Bio between 2008 and 2014.

Admin · 298 views · Leave a comment